G204D (p.Gly204Asp) variant of G6PD (P11413)
G204D (p.Gly204Asp) in G6PD (P11413) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as likely pathogenic in the context of Anemia, nonspherocytic hemolytic, due to G6PD deficiency; not provided. The available variant effect predictions contribute to a CATVariant prioritization score of 0.95 / 1. The record also includes published literature and structural context.
G204D (p.Gly204Asp) variant details
- p.Gly204Asp
- rs2148330566
- ClinGen CA415237781
- ClinVar RCV001509138
- ClinVar RCV002305610
- Likely pathogenic
- Anemia, nonspherocytic hemolytic, due to G6PD deficiency; not provided
- Missense
- Variant Prioritization Score for Impact Estimate 0.95
- AlphaMissense 1.00
- MetaLR 0.99
- MetaSVM 0.91
- PolyPhen-2 0.95
- SIFT 0.00
- EVE 0.87
- ClinVar: Likely pathogenic (Anemia, nonspherocytic hemolytic, due to G6PD deficiency; not pr)
- EBI: Likely pathogenic
- UniProt: Likely pathogenic
- Structural context available
- Cited in: Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for rasburicase therapy in the context of G6PD… (PMID 24787449)